Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey D. Alter Insider Profile
4 Followers
Jeffrey D. Alter, Director at Biora Therapeutics, holds 31.55K shares in Biora Therapeutics (Ticker: BIOR), holds 5.11K shares in Elevance Health (Ticker: ELV).
Jeffrey D. Alter has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey D. Alter holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey D. Alter
Jeffrey D. Alter's Trading History
Biora Therapeutics
Jun 06, 2024
Director
Uninformative Buy
―
$20.50K
Elevance Health
Oct 04, 2021
EVP, IngenioRx & Anthem Health
Uninformative Sell
116.91K
$2.76M
List of latest transactions for each holding click on a transaction to see Jeffrey D. Alter's performance on stock
You May Also Like
Jeffrey D. Alter insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey D. Alter?
The percentage of profitable transactions made by Jeffrey D. Alter is ―.
What is the average return per transaction made by Jeffrey D. Alter?
The average return per transaction made by Jeffrey D. Alter is ―.
What stocks does Jeffrey D. Alter hold?
Jeffrey D. Alter holds: BIOR, ELV stocks.
What was Jeffrey D. Alter’s latest transaction?
Jeffrey D. Alter latest transaction was an Uninformative Buy of ―.
What was Jeffrey D. Alter's most profitable transaction?
Jeffrey D. Alter’s most profitable transaction was an Informative Buy of BIOR stock on December 15, 2020. The return on the trade was -37.50%.
What is Jeffrey D. Alter's role in Biora Therapeutics?
Jeffrey D. Alter's role in Biora Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.